These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37485878)

  • 41. Time to revisit the true role of metformin in type 2 diabetes mellitus.
    Lopez-Candales A; Monte S; Sawalha K; Norgard NB
    Postgrad Med; 2023 Aug; 135(6):539-542. PubMed ID: 37294638
    [No Abstract]   [Full Text] [Related]  

  • 42. [Metformin in adolescents and adults with type 1 diabetes mellitus: not evidence-based].
    Spaans EA; Kleefstra N; van Hateren KJ; Aanstoot HJ; Bilo HJ; Brand PL
    Ned Tijdschr Geneeskd; 2011; 155(39):A3166. PubMed ID: 21961686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension.
    Uehara MH; Kohlmann NE; Zanella MT; Ferreira SR
    Diabetes Obes Metab; 2001 Oct; 3(5):319-25. PubMed ID: 11703421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
    Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
    Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacodynamics of Metformin in Pregnant Women With Gestational Diabetes Mellitus and Nonpregnant Women With Type 2 Diabetes Mellitus.
    Shuster DL; Shireman LM; Ma X; Shen DD; Flood Nichols SK; Ahmed MS; Clark S; Caritis S; Venkataramanan R; Haas DM; Quinney SK; Haneline LS; Tita AT; Manuck TA; Thummel KE; Morris Brown L; Ren Z; Brown Z; Easterling TR; Hebert MF
    J Clin Pharmacol; 2020 Apr; 60(4):540-549. PubMed ID: 31742716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retrospective chart review of children with type 2 diabetes mellitus evaluating the efficacy of metformin vs. insulin vs. combination insulin/metformin.
    Meyer SL; Hoffman RP
    South Med J; 2011 Oct; 104(10):684-8. PubMed ID: 21941156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.
    Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF
    J Clin Pharm Ther; 2009 Feb; 34(1):13-23. PubMed ID: 19125899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome.
    Erensoy H; Niafar M; Ghafarzadeh S; Aghamohammadzadeh N; Nader ND
    Gynecol Endocrinol; 2019 Jan; 35(1):72-75. PubMed ID: 30182764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysis.
    Liu C; Wu D; Zheng X; Li P; Li L
    Diabetes Technol Ther; 2015 Feb; 17(2):142-8. PubMed ID: 25369141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benefits of metformin add-on insulin therapy (MAIT) for HbA1c and lipid profile in adolescents with type 1 diabetes mellitus: preliminary report from a double-blinded, placebo-controlled, randomized clinical trial.
    Sheikhy A; Eydian Z; Fallahzadeh A; Shakiba M; Hajipour M; Alaei M; Mosallanejad A; Saneifard H
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):505-510. PubMed ID: 35249270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of metformin in type II diabetes.
    Epstein S
    Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481
    [No Abstract]   [Full Text] [Related]  

  • 53. Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin.
    Osonoi T; Saito M; Hariya N; Goto M; Mochizuki K
    Peptides; 2016 Dec; 86():118-125. PubMed ID: 27780736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination therapy with metformin and fenofibrate for insulin resistance in obesity.
    Li XM; Li Y; Zhang NN; Xie YH; Shi YQ
    J Int Med Res; 2011; 39(5):1876-82. PubMed ID: 22117989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial.
    Elbarbary NS; Ismail EAR; Ghallab MA
    Diabetes Res Clin Pract; 2022 Apr; 186():109857. PubMed ID: 35351535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin B12 and Folate Concentrations in Recent-onset Type 2 Diabetes and the Effect of Metformin Treatment.
    Kanti G; Anadol-Schmitz E; Bobrov P; Strassburger K; Kahl S; Zaharia OP; Sarabhai T; Karusheva Y; Burkart V; Markgraf DF; Trenkamp S; Ziegler D; Szendroedi J; Roden M;
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32219330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metformin reduces weight gain in overweight/obese adolescents with type 1 diabetes.
    Sharma AM
    Evid Based Med; 2016 Oct; 21(5):186. PubMed ID: 27555640
    [No Abstract]   [Full Text] [Related]  

  • 58. Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Reply to Schatz H [letter].
    Vella S; Buetow L; Royle P; Livingstone S; Petrie JR
    Diabetologia; 2011 Jan; 54(1):203-4. PubMed ID: 21046359
    [No Abstract]   [Full Text] [Related]  

  • 59. [Metformin in the treatment of type 1 diabetics--a placebo controlled study].
    Lacigová S; Rusavý Z; Jankovec Z; Kyselová P
    Cas Lek Cesk; 2001 May; 140(10):302-6. PubMed ID: 11411059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes prevention.
    Brousseau VJ
    N Engl J Med; 2002 Jun; 346(23):1829-30; author reply 1829-30. PubMed ID: 12051267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.